CS396391A3 - Theophyline-containing retarded preparation - Google Patents

Theophyline-containing retarded preparation Download PDF

Info

Publication number
CS396391A3
CS396391A3 CS913963A CS396391A CS396391A3 CS 396391 A3 CS396391 A3 CS 396391A3 CS 913963 A CS913963 A CS 913963A CS 396391 A CS396391 A CS 396391A CS 396391 A3 CS396391 A3 CS 396391A3
Authority
CS
Czechoslovakia
Prior art keywords
theophylline
pellets
release
matrix
hours
Prior art date
Application number
CS913963A
Other languages
Czech (cs)
English (en)
Inventor
Gerald Dr Benedikt
Volker Dr Steinijans
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CS396391A3 publication Critical patent/CS396391A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
CS913963A 1984-12-21 1991-12-20 Theophyline-containing retarded preparation CS396391A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH611184 1984-12-21
CH268385 1985-06-24

Publications (1)

Publication Number Publication Date
CS396391A3 true CS396391A3 (en) 1992-06-17

Family

ID=25691137

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913963A CS396391A3 (en) 1984-12-21 1991-12-20 Theophyline-containing retarded preparation

Country Status (20)

Country Link
US (1) US4803080A (zh)
EP (1) EP0185331B1 (zh)
KR (1) KR920006910B1 (zh)
CN (1) CN1008060B (zh)
AU (1) AU581274B2 (zh)
BG (1) BG60833B2 (zh)
CA (1) CA1261268A (zh)
CS (1) CS396391A3 (zh)
DE (1) DE3572924D1 (zh)
DK (1) DK164843C (zh)
ES (1) ES8704079A1 (zh)
FI (1) FI84782C (zh)
GR (1) GR853051B (zh)
HU (1) HU193359B (zh)
IE (1) IE58246B1 (zh)
IL (1) IL77322A (zh)
NO (1) NO171827C (zh)
NZ (1) NZ214534A (zh)
PT (1) PT81714B (zh)
SK (1) SK278868B6 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
KR20070095456A (ko) * 2005-01-27 2007-09-28 알렘빅 리미티드 레베티라세탐의 서방형 제제
US20080014271A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
CA2841748C (en) 2011-07-15 2021-06-15 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
CN108295058A (zh) 2012-11-13 2018-07-20 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
US20150359771A1 (en) 2013-01-15 2015-12-17 Nusirt Sciences, Inc. Treating pulmonary conditions
EP2968333B1 (en) 2013-03-15 2022-01-12 NuSirt Sciences, Inc. Leucine and nicotinic acid for the reduction of lipid levels
KR20160119863A (ko) 2014-02-27 2016-10-14 뉴서트 사이언시스, 인크. 간 지방증의 감소 또는 예방을 위한 조성물 및 방법
EP3284795B1 (en) * 2015-04-16 2023-08-02 The School Corporation Kansai University Use of a purine base-containing polymer as an anti-ice nucleation activator
CN106176682A (zh) * 2016-08-30 2016-12-07 铜陵翔宇商贸有限公司 茶碱缓释制胶囊剂及其制备方法
WO2020067887A1 (en) 2018-09-24 2020-04-02 Erasmus University Medical Center Rotterdam Specific inhibition of janus kinase 3 (jak3) for modulating anti-tumor immune responses
GB202001237D0 (en) * 2020-01-29 2020-03-11 Sisteks D O O Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1091289B (de) * 1956-01-25 1960-10-20 Hans Lowey Verfahren zur Herstellung einer oral anzuwendenden Arzneiform mit verlaengerter Wirkungsdauer
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
ATE34300T1 (de) * 1981-07-15 1988-06-15 Key Pharma Theophyllin mit verlaengerter abgabe.
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DE3572924D1 (en) 1989-10-19
NO171827C (no) 1993-05-12
CN85109688A (zh) 1986-06-10
PT81714A (de) 1986-01-01
KR860004634A (ko) 1986-07-11
IL77322A (en) 1990-07-12
NO171827B (no) 1993-02-01
ES550291A0 (es) 1987-04-01
CN1008060B (zh) 1990-05-23
DK164843B (da) 1992-08-31
EP0185331B1 (de) 1989-09-13
EP0185331A1 (de) 1986-06-25
AU581274B2 (en) 1989-02-16
BG60833B2 (bg) 1996-04-30
AU5161885A (en) 1986-07-17
HUT40334A (en) 1986-12-28
KR920006910B1 (ko) 1992-08-22
FI84782B (fi) 1991-10-15
NZ214534A (en) 1988-08-30
FI84782C (fi) 1992-01-27
PT81714B (pt) 1988-04-21
NO855215L (no) 1986-06-23
IE58246B1 (en) 1993-08-11
SK278868B6 (sk) 1998-04-08
DK600485D0 (da) 1985-12-20
IE853107L (en) 1986-06-21
CA1261268A (en) 1989-09-26
DK164843C (da) 1993-01-11
ES8704079A1 (es) 1987-04-01
FI854973A0 (fi) 1985-12-16
US4803080A (en) 1989-02-07
GR853051B (zh) 1986-02-03
DK600485A (da) 1986-06-22
FI854973A (fi) 1986-06-22
HU193359B (en) 1987-09-28

Similar Documents

Publication Publication Date Title
CA2042289C (en) Taste masking and sustained release coatings for pharmaceuticals
EP0717986B1 (en) Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally, dextromethorphan
US4806361A (en) Medicaments in sustained release unit dose form
US4851226A (en) Chewable medicament tablet containing means for taste masking
US5405619A (en) Controlled release therapeutic system for liquid pharmaceutical formulations
KR100223131B1 (ko) 서방성 약제 용량 단위
CS396391A3 (en) Theophyline-containing retarded preparation
NZ201008A (en) Oral preparations containing dipyridamole and at least 5 molar equivalents of orally acceptable acidic excipient
JPS63501080A (ja) 活性化合物の放出を制御する新規な製剤およびその製造法
SK280362B6 (sk) Orálny farmaceutický prostriedok obsahujúci terape
JP2599189B2 (ja) 味覚遮蔽剤を含有している咀嚼可能な薬物錠剤
GB2204241A (en) Fat coated pharmaceutical compositions
US5268182A (en) Sustained-release drug dosage units of terazosin
JP2002537323A (ja) ロラタジン及びプソイドエフェドリンを含有する医薬カプセル組成物
EP0538034B1 (en) Taste mask coatings for preparing chewable pharmaceutical tablets
AU661753B2 (en) Prolamine coatings for taste-masking orally-administrable medicaments
JPH02121918A (ja) 液状薬理製剤用制御放出治療システム
JPH06345649A (ja) イプサピロン薬剤組成物
JPH0466846B2 (zh)
KR100193121B1 (ko) 맛 차폐 및 서방성 약제용 피복물
JPS61152629A (ja) 徐放性テオフィリン調剤及びその製法
JPS63162623A (ja) ウラピジルおよび薬理学的に許容可能な脂肪族ジカルボン酸を含有する遅効ペレツト形の医薬

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic